Hims & Hers Health Inc (HIMS) posted a 1.28% change over the last five days signaling a new trend

Hims & Hers Health Inc (NYSE: HIMS) kicked off on Monday, up 1.01% from the previous trading day, before settling in for the closing price of $26.63. Over the past 52 weeks, HIMS has traded in a range of $8.09-$35.02.

Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.

Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!

Get the FREE Report with all the details here.


Sponsored

During the last 5-year period, the sales growth of Consumer Defensive Sector giant was 60.52%. While this was happening, its average annual earnings per share was recorded 796.74%. With a float of $177.44 million, this company’s outstanding shares have now reached $209.44 million.

Let’s determine the extent of company efficiency that accounts for 1046 employees. In terms of profitability, gross margin is 77.58%, operating margin of 2.84%, and the pretax margin is 4.16%.

Hims & Hers Health Inc (HIMS) Breakdown of a Key Holders of the stock

Our next focus will be how large-scale investors are participating in this stock of the Household & Personal Products Industry. The insider ownership of Hims & Hers Health Inc is 18.78%, while institutional ownership is 56.02%. The most recent insider transaction that took place on Jan 02 ’25, was worth 285,784. In this transaction Chief Financial Officer of this company sold 11,581 shares at a rate of $24.68, taking the stock ownership to the 123,221 shares. Before that another transaction happened on Jan 02 ’25, when Company’s Chief Commercial Officer sold 2,055 for $24.62, making the entire transaction worth $50,594. This insider now owns 193,601 shares in total.

Hims & Hers Health Inc (HIMS) Recent Fiscal highlights

According to the Wall Street analysts, stocks earnings will be around 796.74% per share during the next fiscal year.

Hims & Hers Health Inc (NYSE: HIMS) Trading Performance Indicators

Take a look at Hims & Hers Health Inc’s (HIMS) current performance indicators. Last quarter, stock had a quick ratio of 1.82. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 5.00. Likewise, its price to free cash flow for the trailing twelve months is 41.51.

For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 0.43, a number that is poised to hit 0.17 in the next quarter and is forecasted to reach 0.85 in one year’s time.

Technical Analysis of Hims & Hers Health Inc (HIMS)

Looking closely at Hims & Hers Health Inc (NYSE: HIMS), its last 5-days average volume was 8.8 million, which is a jump from its year-to-date volume of 8.62 million. As of the previous 9 days, the stock’s Stochastic %D was 34.86%. Additionally, its Average True Range was 2.32.

During the past 100 days, Hims & Hers Health Inc’s (HIMS) raw stochastic average was set at 62.32%, which indicates a significant increase from 30.90% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 75.88% in the past 14 days, which was lower than the 101.42% volatility it showed in the past 100 days.

At the time of writing, stock’s 50-day Moving Average is $26.41, while its 200-day Moving Average is $19.77. However, in the short run, Hims & Hers Health Inc’s stock first resistance to watch stands at $27.95. Second resistance stands at $28.99. The third major resistance level sits at $29.79. If the price goes on to break the first support level at $26.11, it is likely to go to the next support level at $25.31. Now, if the price goes above the second support level, the third support stands at $24.27.

Hims & Hers Health Inc (NYSE: HIMS) Key Stats

The company with the Market Capitalisation of 6.21 billion has total of 218,479K Shares Outstanding. Its annual sales at the moment are 872,000 K in contrast with the sum of -23,550 K annual income. Company’s last quarter sales were recorded 401,560 K and last quarter income was 75,590 K.